Stock APDN APPLIED DNA SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Applied DNA Sciences, Inc.

Equities

APDN

US03815U4094

Real-time Estimate Cboe BZX
Other stock markets
 10:31:26 2024-05-21 am EDT 		5-day change 1st Jan Change
2.08 USD +6.12% Intraday chart for Applied DNA Sciences, Inc. -34.78% -82.98%
May. 14 Maxim Downgrades Applied DNA Sciences to Hold From Buy MT
May. 13 Top Premarket Decliners MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Downgrades Applied DNA Sciences to Hold From Buy
MT
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
AQ
Top Premarket Decliners
MT
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot
AQ
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q2 Revenue $929,631
MT
Applied DNA Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
CI
Applied DNA Sciences Regains Nasdaq Minimum Bid Price Requirement
MT
Banned Chinese cotton found in 19% of US retailers' merchandise, study shows
RE
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program
AQ
Applied DNA Sciences, Inc. Receives Contract by HDT Bio for Rapid Vaccine Development Program
CI
Reverse Split: 1 of 20
FA
Certain Warrants of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.
CI
Certain Options of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.
CI
Certain Common Stock of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.
CI
Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress
AQ
Applied DNA Sciences, Inc. to Showcase Linea DNA and Linea IVT Platforms At 24Th Annual World Vaccine Congress
CI
Applied DNA Sciences Files Prospectus for Potential Secondary Stock Offerings
MT
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot
AQ
Transcript : Applied DNA Sciences, Inc., Q1 2024 Earnings Call, Feb 08, 2024
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q1 Revenue $891,164
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APDN Stock
  4. News Applied DNA Sciences, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW